Get started
Author

Maria Hjorth

Observed name: Hjorth, Maria
Observed institution: Linköping University
ORCID: 0000-0002-4195-9387
Observed ORCID: 0000-0002-4195-9387
OpenAlex ID: A5064175308
GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
2008 · Johnny Ludvigsson, Maria Faresjö, et al. · New England Journal of Medicine · 520
PDF
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients
2010 · Maria Hjorth, Stina Axelsson, et al. · Clinical Immunology · 72
T cell perturbations persist for at least 6 months following hospitalization for COVID-19
2022 · Melissa Govender, Francis R. Hopkins, et al. · Frontiers in Immunology · 44
Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
2011 · Stina Axelsson, Mikael Chéramy, et al. · PLoS ONE · 41
PDF
Regulatory T‐cell Subpopulations in Severe or Early‐onset Preeclampsia
2015 · Roland Boij, Jenny Mjösberg, et al. · American Journal of Reproductive Immunology · 39
Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets
2020 · Maria Hjorth, Nicolae Dandu, et al. · PLoS ONE · 34
PDF
Early induction of GAD65‐reactive Th2 response in type 1 diabetic children treated with alum‐formulated GAD65
2010 · Stina Axelsson, Maria Hjorth, et al. · Diabetes/Metabolism Research and Reviews · 31
SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
2022 · Johanna Sjöwall, Maria Hjorth, et al. · Journal of Clinical Medicine · 7
PDF
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
2022 · Katarina Nyström, Maria Hjorth, et al. · BMC Infectious Diseases · 7
PDF
Immunological characterization of IgG subclass deficiency reveals decreased Tregs and increased circulating costimulatory and regulatory immune checkpoints
2024 · Per Wågström, Maria Hjorth, et al. · Frontiers in Immunology · 5
PDF
Immunological profile and aspects of immunotherapy in type 1 diabetes
2010 · Maria Hjorth · DiVA (Linkoping University) · 1
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells and reduces CD4+ cell activation in type 1 diabetic patients
2009 · Maria Hjorth, Stina Axelsson, et al. · 1
Clinical and immunological characterization of IgG subclass deficiency reveals that low levels of pneumococcal antibodies associate with need of immunoglobulin replacement therapy
2024 · Per Wågström, Maria Hjorth, et al. · Research Square
PDF
Treatment with alum-formulated GAD65 in type 1 diabetic children results in early induction of Th2 responses
2009 · Stina Axelsson, Maria Hjorth, et al.
GAD-alum treatment induces GAD-specific FOXP3+ cells in type 1 diabetic children
2009 · Maria Hjorth, Stina Axelsson, et al.
Specific immunomodulatory effect of GAD(65) in type 1 diabetics
2009 · Rosaura Casas, Maria Hjorth, et al.
Works count: 20
Citation count: 802
H-index: 7
I10-index: 7
Year
Topic
Type